7 completed, 5 unknown, 2 terminated, 1 recruiting. 15 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 15 | Completed 7, Unknown 5, Terminated 2, Recruiting 1 |
Follow Vascular Calcification: new trials by email Literature Review of Vascular Calcification trials Research Report on Vascular Calcification
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GUIDE-CAC: Statin-Ezetimibe Without Aspirin vs. Statin Monotherapy With Aspirin in High Coronary Calcification Pitavastatin 4mg and ezetimibe 10mg, taken once daily, Pitavastatin 2 mg with aspirin 100 mg, taken once daily. - Primary Prevention, Vascular Calcification | Phase 4 | Recruiting | Asan Medical Center | 7435 | 2025-07-09 | 2025-08-07 |
| Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients palicalcitol - Chronic Kidney Disease-Mineral and Bone Disorder | Phase 4 | Unknown | Xiaoyan Jia | 80 | 2023-04-01 | 2024-03-08 |
| Study Evaluating Denosumab on Bone and Vascular Metabolism in Osteoporotic Chronic Kidney Disease Denosumab, NaCl (placebo) - Female With Osteoporosis and Chronic Kidney Disease | Phase 4 | Terminated | University Hospital, Montpellier | 4 | 2018-11-19 | 2023-08-09 |
| Vitamin k1 and Its Relation to Vascular Calcification in Hemodialysis Patients oral vitamin k1 (phylloquinone) - Vascular Calcification | Phase 4 | Completed | Assiut University | 120 | 2018-01-01 | 2021-10-05 |
| Vitamin K2 Supplementation and Vascular Calcification Vitamin K 2 - Renal Disease | Phase 4 | Completed | Catholic University of Salta | 59 | 2016-12-01 | 2020-09-09 |
| Risk Factors for Vascular Calcifications in Hemodialysis Patients: to What Extent is Vitamin K2 Deficiency Involved? Menaquinone - Vascular Calcifications | Phase 4 | Completed | Saint-Joseph University | 50 | 2016-08-01 | 2016-09-20 |
| Effect on Vascular Calcification of Replacing Warfarin by Rivaroxaban With or Without VitK2 in Hemodialysis Patients rivaroxaban, Vitamin K2 - Vascular Calcification | Phase 4 | Completed | Onze Lieve Vrouw Hospital | 117 | 2015-11-01 | 2019-01-28 |
| Effects of Cholecalciferol on Osteoprotegerin Levels in Patients on Peritoneal Dialysis Cholecalciferol, Placebo - Vitamin D Deficiency, Vascular Calcification | Phase 4 | Unknown | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 58 | 2015-10-01 | 2017-03-24 |
| Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2 Calcitriol, placebo - Chronic Kidney Disease Stage 1, Chronic Kidney Disease Stage 2 | Phase 4 | Unknown | Taixing People's Hospital | 300 | 2015-07-01 | 2015-06-08 |
| Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia Lanthanum carbonate, Calcium Carbonate - Renal Insufficiency, Chronic, Hyperphosphatemia | Phase 4 | Unknown | Osaka University | 60 | 2014-09-01 | 2021-02-25 |
| Effect of Phosphate Binders on Markers of Vascular Health in Chronic Kidney Disease Stages 3 and 4 Sevelamer carbonate, Calcium acetate - Chronic Kidney Disease | Phase 4 | Terminated | Albany College of Pharmacy and Health Sciences | 30 | 2011-01-01 | 2016-01-14 |
| Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis Patients Cinacalcet, Surgical total parathyroidectomy with forearm autografting - Kidney Failure, Secondary Hyperparathyroidism | Phase 4 | Completed | The University of Hong Kong | 67 | 2010-05-10 | 2021-10-12 |
| Study of the Effect of Alendronate on Vascular Calcification and Arterial Stiffness in Chronic Kidney Disease Alendronate, Placebo - Vascular Calcification, Arteriosclerosis | Phase 4 | Completed | Monash University | 50 | 2007-01-01 | 2010-02-09 |
| ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis cinacalcet - Chronic Kidney Disease, End Stage Renal Disease | Phase 4 | Completed | Amgen | 360 | 2006-09-01 | 2014-07-23 |
| Alendronate for Vascular Calcification in Peritoneal Dialysis Patients? alendronate (Fosamax) - Peritoneal Dialysis | Phase 4 | Unknown | Far Eastern Memorial Hospital | 50 | 2006-03-01 | 2006-03-07 |
Renal Insufficiency, Chronic (6) · Cardiovascular Diseases (2) · Hyperparathyroidism, Secondary (2) · Kidney Diseases (2) · Renal Insufficiency (2) · Arteriosclerosis (1) · Bone Diseases, Metabolic (1) · Calcinosis (1) · Chronic Kidney Disease-Mineral and Bone Disorder (1) · Hyperparathyroidism (1) · Hyperphosphatemia (1) · Kidney Failure, Chronic (1) · Osteoporosis (1) · Vascular Diseases (1)
Calcium Metabolism Disorders (15) · Metabolic Diseases (15) · Nutritional and Metabolic Diseases (15) · Calcinosis (14) · Female Urogenital Diseases (9) · Female Urogenital Diseases and Pregnancy Complications (9) · Male Urogenital Diseases (9) · Urogenital Diseases (9) · Urologic Diseases (9) · Chronic Disease (7) · Disease Attributes (7) · Kidney Diseases (7) · Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Renal Insufficiency (5)
Vitamin K 2 (3) · Alendronate (2) · Calcitriol (2) · Cinacalcet (2) · Aspirin (1) · Calcium Carbonate (1) · Cholecalciferol (1) · Denosumab (1) · Ezetimibe (1) · Rivaroxaban (1) · Sevelamer (1) · Vitamin D (1) · Vitamin K 1 (1) · calcium acetate (1) · lanthanum carbonate (1)
Albany College of Pharmacy and Health Sciences (1) · Amgen (1) · Asan Medical Center (1) · Assiut University (1) · Catholic University of Salta (1) · Far Eastern Memorial Hospital (1) · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (1) · Monash University (1) · Onze Lieve Vrouw Hospital (1) · Osaka University (1) · Saint-Joseph University (1) · Taixing People's Hospital (1) · The University of Hong Kong (1) · University Hospital, Montpellier (1) · Xiaoyan Jia (1)
China (2) · Australia (1) · Belgium (1) · Egypt (1) · France (1) · Hong Kong (1) · Japan (1) · Lebanon (1) · Mexico (1) · South Korea (1) · Taiwan (1) · United States (1)
Angela YM Wang, MD, PhD (1) · Chun-Fu Lai, M.D. (1) · Darius L Mason, Pharm.D. (1) · Mabel Aoun, MD (1) · Peter G Kerr, MBBS FRACP (1) · Ricardo Correa-Rotter, MD (1) · Takayuki Hamano, MD, PhD (1)
PMID 34231877, PMID 10089993, PMID 10584989, PMID 10816185, PMID 12937218, PMID 15284307, PMID 15810001, PMID 17130273, PMID 17468488, PMID 18046319, PMID 18094365, PMID 18838561, PMID 19007931, PMID 19082528, PMID 20133489, PMID 20649879, PMID 21233416, PMID 21781006, PMID 22169620, PMID 22267443, PMID 22289649, PMID 22516722, PMID 22648294, PMID 23535831, PMID 24072176, PMID 24285428, PMID 24326161, PMID 24400802, PMID 24429407, PMID 24685669, PMID 24944752, PMID 25744701, PMID 25770176, PMID 25804678, PMID 26293840, PMID 26295257, PMID 26985380, PMID 28592319, PMID 29531291, PMID 34599865, PMID 36869794, PMID 38040277, PMID 38189593, PMID 9194765